Mozart is orchestrating a novel regulatory CD8 T cell network to discover and develop disease modifying therapies that restore immune balance in autoimmune & inflammatory diseases.
Our Science
Building on seminal work of our scientific founders, we are capitalizing on a novel regulatory CD8 T cell network to develop disease modifying CD8 Treg modulators across a spectrum of autoimmune diseases.
Pipeline
Mozart is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance and avert the progressive damage caused by an autoreactive and pathogenic immune response.